collaborators

1 paper

cs.LG2026

Externally Validated Longitudinal GRU Model for Visit-Level 180-Day Mortality Risk in Metastatic Castration-Resistant Prostate Cancer

Javier Mencia-Ledo, Mohammad Noaeen, Zahra Shakeri

Metastatic castration-resistant prostate cancer (mCRPC) is a highly aggressive disease with poor prognosis and heterogeneous treatment response. In this work, we developed and exte…